GHTC responded to a public request for comment on the pandemic accord negotiations that was released by the US Department of Health and Human Services' Office of Global Affairs. GHTC's comments focused on the need for the accord to feature provisions that incentivize continuous research and development, facilitate equitable access to medical countermeasures, and strengthen regulatory capacity.
News & Insights: Announcement
Check out the latest news and announcements from GHTC.
GHTC contributed to statements delivered by the Global Health Council at the 154th World Health Organization (WHO) Executive Board (EB) meeting on global health R&D agenda items: neglected tropical diseases (NTDs), tuberculosis (TB), and antimicrobial resistance (AMR).
- In the media
Latest from the Breakthroughs Blog
Read stories about bright ideas and bold innovations in global health.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Learn more about upcoming events hosted by or featuring GHTC and its members.
Community Breakfast Club sessions at the 2024 Conference on Retroviruses and Opportunistic Infections
AVAC, Conference on Retroviruses and Opportunistic Infections Community Liaison Subcommittee, European AIDS Treatment Group
Drugs for Neglected Diseases initiative, National Institutes of Health, Clinical Research Malaysia
AVAC's The Choice Agenda
Global Accelerator for Pediatric Formulation, Elizabeth Glaser Pediatric AIDS Foundation, Medicines Patent Pool, and Drugs for Neglected Diseases initiative
- GHTC event